Lyra Therapeutics raises $56 million in IPO, priced at high end of range [MarketWatch]
Lyra Therapeutics, Inc. (LYRA)
Company Research
Source: MarketWatch
Lyra Therapeutics Inc. , a biotech specializing in treatments for ear, nose and throat diseases, priced its initial public offering late Thursday at $16 a share, the high end of its price range. The company sold 3.5 million shares to raise $56 million. BofA, Jefferies, William Blair and BTIG are underwriters on the deal. Proceeds will be used to fund clinical trials, for R&D and for platform development, working capital and other general corporate purposes. The stock will start trading on Nasdaq later Friday, under the ticker symbol "LYRA."
Show less
Read more
Impact Snapshot
Event Time:
LYRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LYRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LYRA alerts
High impacting Lyra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LYRA
News
- Lyra Therapeutics GAAP EPS of -$3.38 beats by $0.98 [Seeking Alpha]Seeking Alpha
- Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate UpdateGlobeNewswire
- Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study [Yahoo! Finance]Yahoo! Finance
- Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 StudyGlobeNewswire
LYRA
Sec Filings
- 11/25/25 - Form SCHEDULE
- 11/18/25 - Form SCHEDULE
- 11/12/25 - Form 10-Q
- LYRA's page on the SEC website